Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.96
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Aura Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 447 | 346 | 411 | 436 | 389 | 496 | |
| Market Cap Growth | 79.00% | -15.71% | -5.92% | 12.22% | -21.59% | - | |
| Enterprise Value | 320 | 202 | 255 | 308 | 298 | 631 | |
| Last Close Price | 6.96 | 5.45 | 8.22 | 8.86 | 10.50 | 16.98 | |
| PB Ratio | 3.23 | 2.53 | 2.70 | 1.93 | 1.99 | 3.26 | |
| P/TBV Ratio | 3.26 | 2.53 | 2.70 | 1.93 | 1.99 | 3.26 | |
| Debt / Equity Ratio | 0.13 | 0.13 | 0.12 | 0.09 | 0.11 | 0.01 | |
| Net Debt / Equity Ratio | -0.93 | -0.93 | -0.87 | -0.91 | -0.86 | -0.97 | |
| Net Debt / EBITDA Ratio | 1.14 | 1.14 | 1.39 | 2.47 | 2.84 | 4.30 | |
| Net Debt / FCF Ratio | 1.49 | 1.49 | 1.63 | 3.20 | 3.02 | 4.29 | |
| Quick Ratio | 7.85 | 7.85 | 10.13 | 18.30 | 18.06 | 20.27 | |
| Current Ratio | 8.15 | 8.15 | 10.77 | 18.76 | 18.81 | 20.90 | |
| Return on Equity (ROE) | -73.52% | -73.52% | -46.01% | -36.26% | -33.78% | -41.07% | |
| Return on Assets (ROA) | -40.06% | -40.06% | -27.46% | -22.18% | -19.63% | -24.19% | |
| Return on Capital Employed (ROCE) | -74.70% | -74.70% | -57.40% | -35.00% | -28.20% | -23.10% | |
| Earnings Yield | -23.77% | -30.68% | -21.17% | -17.51% | -15.11% | -7.11% | |
| FCF Yield | -19.07% | -24.61% | -19.74% | -14.79% | -14.32% | -6.96% | |
| Buyback Yield / Dilution | -21.52% | -21.52% | -25.32% | -32.34% | -480.18% | -1305.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.